Patients aged @ years with glycated hemoglobin ( HbA@c ) > @ % to @ % receiving stable metformin doses ( @mg/d ) were randomized @:@ to add-on therapy with saxagliptin @mg/d or glipizide @ to @mg/d ( titrated to optimal effect or highest tolerable dose during the initial @ weeks ) .